ArticleCancer biomarkers : section A of Disease markers2025

Unraveling the role of PREX2 mutations as a biomarker for immunotherapy response in colorectal cancer.

Huan Peng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.